Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP212522.RAeAGGJe011GABjb5gsV5gH87-mt3ahIX_GxBHeVNx4EA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP212522.RAeAGGJe011GABjb5gsV5gH87-mt3ahIX_GxBHeVNx4EA130_assertion type Assertion NP212522.RAeAGGJe011GABjb5gsV5gH87-mt3ahIX_GxBHeVNx4EA130_head.
- NP212522.RAeAGGJe011GABjb5gsV5gH87-mt3ahIX_GxBHeVNx4EA130_assertion description "[(i) FN from fetal connective tissue, placenta, amniotic fluid, hepatoma, and colon carcinoma as well as cell lines from fetal tissues (WI-38), hepatomas (HuH-6 and HuH-7), and sarcoma (VA13) was characterized by the presence of the FDC-6-defined domain and by a high molecular weight (subunit Mr, 310,000-335,000).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP212522.RAeAGGJe011GABjb5gsV5gH87-mt3ahIX_GxBHeVNx4EA130_provenance.
- NP212522.RAeAGGJe011GABjb5gsV5gH87-mt3ahIX_GxBHeVNx4EA130_assertion evidence source_evidence_literature NP212522.RAeAGGJe011GABjb5gsV5gH87-mt3ahIX_GxBHeVNx4EA130_provenance.
- NP212522.RAeAGGJe011GABjb5gsV5gH87-mt3ahIX_GxBHeVNx4EA130_assertion SIO_000772 2995969 NP212522.RAeAGGJe011GABjb5gsV5gH87-mt3ahIX_GxBHeVNx4EA130_provenance.
- NP212522.RAeAGGJe011GABjb5gsV5gH87-mt3ahIX_GxBHeVNx4EA130_assertion wasDerivedFrom befree-20140225 NP212522.RAeAGGJe011GABjb5gsV5gH87-mt3ahIX_GxBHeVNx4EA130_provenance.
- NP212522.RAeAGGJe011GABjb5gsV5gH87-mt3ahIX_GxBHeVNx4EA130_assertion wasGeneratedBy ECO_0000203 NP212522.RAeAGGJe011GABjb5gsV5gH87-mt3ahIX_GxBHeVNx4EA130_provenance.